Skip to content
Home/Companies/MedTech/Leuko
Leuko

Leuko

MedTech·United States·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns Leuko?

Leuko is currently owned by Nina Capital through Nina Capital Fund I (2019 vintage), since 2019.

Hand-verified · updated 2026-08-09

Nina Capital
Investor
Nina Capital
Nina Capital Fund I · 2019 · VC

Key facts

HQUnited States
SectorMedTech
StatusActive
Websiteleuko.com

More from Nina Capital Fund I

Other portfolio companies in the same fund.

Cardiomatics
Cardiomatics
Active
MedTechPoland· 2021
EarlySight
EarlySight
Active
HealthTechSwitzerland· 2021
Lena
Lena
Active
HealthTechUnited States· 2021
Move Up Care
Active
HealthTechBelgium· 2021
Promptly Health
Promptly Health
Active
HealthTechPortugal· 2021
Replica Analytics
Exited 2022
HealthTechCanada· 2021
to

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Optos
Exited 2015
Amadeus Capital PartnersUK
to
Axomove
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Clee Medical
Clee Medical
Active
High-Tech Gruenderfonds (HTGF)Switzerland· 2026
CollimateHealth
Active
Caesar Ventures ManagementGermany· 2026
Track Leuko

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Leuko.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue